States file third suit against generics industry

Ben Remaly

11 June 2020

Credit: Shutterstock/SMAK_Photo

A coalition of 51 US states and territories have filed their third sweeping antitrust lawsuit against the generic pharmaceuticals industry, alleging a massive conspiracy to fix prices for topical skin treatments.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

The doing it Alone Star State: The Tipline for 1 June 2023
Texas might have California beat in size, but it can hardly say the same for setting regulatory standards. With lawmakers in the nation’s capital in a constant deadlock, the Golden State has taken the progressive lead on everything from the environment to privacy. Now Sacramento has its sights trained on competition policy, with legislators boosting bills that would break up Live Nation/Ticketmaster and require Big Tech companies to pay news publishers for their content. …
To AI or not to AI: The Tipline for 31 May 2023
All hat, no cattle: The Tipline for 30 May 2023

States file third suit against generics industry

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Ben Remaly